nodes	percent_of_prediction	percent_of_DWPC	metapath
Arformoterol—CYP2A6—stomach cancer	0.264	0.359	CbGaD
Arformoterol—ADRB1—stomach cancer	0.256	0.348	CbGaD
Arformoterol—ADRB2—stomach cancer	0.216	0.293	CbGaD
Arformoterol—CYP2A6—Fluorouracil—stomach cancer	0.0446	0.476	CbGbCtD
Arformoterol—CYP2C9—Capecitabine—stomach cancer	0.0259	0.276	CbGbCtD
Arformoterol—CYP2C9—Fluorouracil—stomach cancer	0.0153	0.164	CbGbCtD
Arformoterol—CYP2D6—Doxorubicin—stomach cancer	0.00799	0.0851	CbGbCtD
Arformoterol—Isoprenaline—MAPK1—stomach cancer	0.000838	0.121	CrCbGaD
Arformoterol—Dobutamine—CA2—stomach cancer	0.000632	0.091	CrCbGaD
Arformoterol—Fenoterol—ADRB1—stomach cancer	0.000511	0.0736	CrCbGaD
Arformoterol—Arbutamine—ADRB1—stomach cancer	0.000478	0.0688	CrCbGaD
Arformoterol—Formoterol—CYP2A6—stomach cancer	0.000478	0.0688	CrCbGaD
Arformoterol—Formoterol—ADRB1—stomach cancer	0.000464	0.0668	CrCbGaD
Arformoterol—Dobutamine—ADRB1—stomach cancer	0.00044	0.0634	CrCbGaD
Arformoterol—Fenoterol—ADRB2—stomach cancer	0.00043	0.0619	CrCbGaD
Arformoterol—Ritodrine—ADRB2—stomach cancer	0.00043	0.0619	CrCbGaD
Arformoterol—Arbutamine—ADRB2—stomach cancer	0.000402	0.0579	CrCbGaD
Arformoterol—Formoterol—ADRB2—stomach cancer	0.00039	0.0562	CrCbGaD
Arformoterol—Dobutamine—ADRB2—stomach cancer	0.00037	0.0533	CrCbGaD
Arformoterol—Labetalol—ADRB1—stomach cancer	0.000339	0.0488	CrCbGaD
Arformoterol—Labetalol—ADRB2—stomach cancer	0.000285	0.0411	CrCbGaD
Arformoterol—Isoprenaline—ADRB1—stomach cancer	0.00025	0.0359	CrCbGaD
Arformoterol—Isoprenaline—ADRB2—stomach cancer	0.00021	0.0302	CrCbGaD
Arformoterol—Oedema—Docetaxel—stomach cancer	0.000128	0.000897	CcSEcCtD
Arformoterol—Discomfort—Capecitabine—stomach cancer	0.000128	0.000895	CcSEcCtD
Arformoterol—Urethral disorder—Methotrexate—stomach cancer	0.000128	0.000892	CcSEcCtD
Arformoterol—Infection—Docetaxel—stomach cancer	0.000128	0.000891	CcSEcCtD
Arformoterol—Sinusitis—Epirubicin—stomach cancer	0.000127	0.00089	CcSEcCtD
Arformoterol—Hyperglycaemia—Doxorubicin—stomach cancer	0.000127	0.000888	CcSEcCtD
Arformoterol—Diarrhoea—Irinotecan—stomach cancer	0.000127	0.000888	CcSEcCtD
Arformoterol—Dry mouth—Capecitabine—stomach cancer	0.000127	0.000886	CcSEcCtD
Arformoterol—Nervous system disorder—Docetaxel—stomach cancer	0.000126	0.00088	CcSEcCtD
Arformoterol—Pruritus—Fluorouracil—stomach cancer	0.000126	0.000879	CcSEcCtD
Arformoterol—Visual impairment—Methotrexate—stomach cancer	0.000126	0.000877	CcSEcCtD
Arformoterol—Tachycardia—Docetaxel—stomach cancer	0.000125	0.000875	CcSEcCtD
Arformoterol—Skin disorder—Docetaxel—stomach cancer	0.000125	0.000871	CcSEcCtD
Arformoterol—Oedema—Capecitabine—stomach cancer	0.000124	0.000868	CcSEcCtD
Arformoterol—Infection—Capecitabine—stomach cancer	0.000123	0.000863	CcSEcCtD
Arformoterol—Dizziness—Irinotecan—stomach cancer	0.000123	0.000858	CcSEcCtD
Arformoterol—Rhinitis—Epirubicin—stomach cancer	0.000122	0.000854	CcSEcCtD
Arformoterol—Urinary tract infection—Doxorubicin—stomach cancer	0.000122	0.000853	CcSEcCtD
Arformoterol—Conjunctivitis—Doxorubicin—stomach cancer	0.000122	0.000853	CcSEcCtD
Arformoterol—Nervous system disorder—Capecitabine—stomach cancer	0.000122	0.000852	CcSEcCtD
Arformoterol—Diarrhoea—Fluorouracil—stomach cancer	0.000122	0.00085	CcSEcCtD
Arformoterol—Tachycardia—Capecitabine—stomach cancer	0.000121	0.000848	CcSEcCtD
Arformoterol—Pharyngitis—Epirubicin—stomach cancer	0.000121	0.000845	CcSEcCtD
Arformoterol—Cardiac disorder—Methotrexate—stomach cancer	0.000121	0.000844	CcSEcCtD
Arformoterol—Skin disorder—Capecitabine—stomach cancer	0.000121	0.000843	CcSEcCtD
Arformoterol—Urinary tract disorder—Epirubicin—stomach cancer	0.00012	0.000841	CcSEcCtD
Arformoterol—Oedema peripheral—Epirubicin—stomach cancer	0.00012	0.000839	CcSEcCtD
Arformoterol—Hypotension—Docetaxel—stomach cancer	0.00012	0.000838	CcSEcCtD
Arformoterol—Haematuria—Doxorubicin—stomach cancer	0.00012	0.000837	CcSEcCtD
Arformoterol—Connective tissue disorder—Epirubicin—stomach cancer	0.00012	0.000837	CcSEcCtD
Arformoterol—Urethral disorder—Epirubicin—stomach cancer	0.000119	0.000835	CcSEcCtD
Arformoterol—Vomiting—Irinotecan—stomach cancer	0.000118	0.000825	CcSEcCtD
Arformoterol—Sinusitis—Doxorubicin—stomach cancer	0.000118	0.000823	CcSEcCtD
Arformoterol—Immune system disorder—Methotrexate—stomach cancer	0.000118	0.000822	CcSEcCtD
Arformoterol—Dizziness—Fluorouracil—stomach cancer	0.000118	0.000822	CcSEcCtD
Arformoterol—Visual impairment—Epirubicin—stomach cancer	0.000117	0.000821	CcSEcCtD
Arformoterol—Mediastinal disorder—Methotrexate—stomach cancer	0.000117	0.00082	CcSEcCtD
Arformoterol—Rash—Irinotecan—stomach cancer	0.000117	0.000818	CcSEcCtD
Arformoterol—Dermatitis—Irinotecan—stomach cancer	0.000117	0.000817	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000117	0.000817	CcSEcCtD
Arformoterol—Headache—Irinotecan—stomach cancer	0.000116	0.000813	CcSEcCtD
Arformoterol—Hypotension—Capecitabine—stomach cancer	0.000116	0.000811	CcSEcCtD
Arformoterol—Insomnia—Docetaxel—stomach cancer	0.000116	0.000811	CcSEcCtD
Arformoterol—Dyspnoea—Docetaxel—stomach cancer	0.000114	0.0008	CcSEcCtD
Arformoterol—Somnolence—Docetaxel—stomach cancer	0.000114	0.000797	CcSEcCtD
Arformoterol—Mental disorder—Methotrexate—stomach cancer	0.000114	0.000797	CcSEcCtD
Arformoterol—Malnutrition—Methotrexate—stomach cancer	0.000113	0.000792	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000113	0.000791	CcSEcCtD
Arformoterol—Cardiac disorder—Epirubicin—stomach cancer	0.000113	0.00079	CcSEcCtD
Arformoterol—Vomiting—Fluorouracil—stomach cancer	0.000113	0.00079	CcSEcCtD
Arformoterol—Rhinitis—Doxorubicin—stomach cancer	0.000113	0.00079	CcSEcCtD
Arformoterol—Dyspepsia—Docetaxel—stomach cancer	0.000113	0.00079	CcSEcCtD
Arformoterol—Insomnia—Capecitabine—stomach cancer	0.000112	0.000785	CcSEcCtD
Arformoterol—Rash—Fluorouracil—stomach cancer	0.000112	0.000784	CcSEcCtD
Arformoterol—Dermatitis—Fluorouracil—stomach cancer	0.000112	0.000783	CcSEcCtD
Arformoterol—Pharyngitis—Doxorubicin—stomach cancer	0.000112	0.000782	CcSEcCtD
Arformoterol—Headache—Fluorouracil—stomach cancer	0.000111	0.000778	CcSEcCtD
Arformoterol—Urinary tract disorder—Doxorubicin—stomach cancer	0.000111	0.000778	CcSEcCtD
Arformoterol—Oedema peripheral—Doxorubicin—stomach cancer	0.000111	0.000776	CcSEcCtD
Arformoterol—Dysgeusia—Methotrexate—stomach cancer	0.000111	0.000776	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000111	0.000774	CcSEcCtD
Arformoterol—Connective tissue disorder—Doxorubicin—stomach cancer	0.000111	0.000774	CcSEcCtD
Arformoterol—Dyspnoea—Capecitabine—stomach cancer	0.000111	0.000774	CcSEcCtD
Arformoterol—Fatigue—Docetaxel—stomach cancer	0.000111	0.000773	CcSEcCtD
Arformoterol—Urethral disorder—Doxorubicin—stomach cancer	0.000111	0.000772	CcSEcCtD
Arformoterol—Nausea—Irinotecan—stomach cancer	0.00011	0.000771	CcSEcCtD
Arformoterol—Immune system disorder—Epirubicin—stomach cancer	0.00011	0.000769	CcSEcCtD
Arformoterol—Mediastinal disorder—Epirubicin—stomach cancer	0.00011	0.000767	CcSEcCtD
Arformoterol—Pain—Docetaxel—stomach cancer	0.00011	0.000767	CcSEcCtD
Arformoterol—Constipation—Docetaxel—stomach cancer	0.00011	0.000767	CcSEcCtD
Arformoterol—Back pain—Methotrexate—stomach cancer	0.00011	0.000766	CcSEcCtD
Arformoterol—Dyspepsia—Capecitabine—stomach cancer	0.000109	0.000764	CcSEcCtD
Arformoterol—Arrhythmia—Epirubicin—stomach cancer	0.000109	0.000761	CcSEcCtD
Arformoterol—Visual impairment—Doxorubicin—stomach cancer	0.000109	0.000759	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000107	0.00075	CcSEcCtD
Arformoterol—Fatigue—Capecitabine—stomach cancer	0.000107	0.000749	CcSEcCtD
Arformoterol—Mental disorder—Epirubicin—stomach cancer	0.000107	0.000746	CcSEcCtD
Arformoterol—Pain—Capecitabine—stomach cancer	0.000106	0.000743	CcSEcCtD
Arformoterol—Constipation—Capecitabine—stomach cancer	0.000106	0.000743	CcSEcCtD
Arformoterol—Malnutrition—Epirubicin—stomach cancer	0.000106	0.000741	CcSEcCtD
Arformoterol—Feeling abnormal—Docetaxel—stomach cancer	0.000106	0.000739	CcSEcCtD
Arformoterol—Nausea—Fluorouracil—stomach cancer	0.000106	0.000738	CcSEcCtD
Arformoterol—Ill-defined disorder—Methotrexate—stomach cancer	0.000105	0.000735	CcSEcCtD
Arformoterol—Gastrointestinal pain—Docetaxel—stomach cancer	0.000105	0.000733	CcSEcCtD
Arformoterol—Cardiac disorder—Doxorubicin—stomach cancer	0.000105	0.000731	CcSEcCtD
Arformoterol—Tension—Epirubicin—stomach cancer	0.000104	0.000727	CcSEcCtD
Arformoterol—Dysgeusia—Epirubicin—stomach cancer	0.000104	0.000726	CcSEcCtD
Arformoterol—Nervousness—Epirubicin—stomach cancer	0.000103	0.00072	CcSEcCtD
Arformoterol—Back pain—Epirubicin—stomach cancer	0.000103	0.000717	CcSEcCtD
Arformoterol—Feeling abnormal—Capecitabine—stomach cancer	0.000102	0.000716	CcSEcCtD
Arformoterol—Malaise—Methotrexate—stomach cancer	0.000102	0.000714	CcSEcCtD
Arformoterol—Muscle spasms—Epirubicin—stomach cancer	0.000102	0.000713	CcSEcCtD
Arformoterol—Immune system disorder—Doxorubicin—stomach cancer	0.000102	0.000712	CcSEcCtD
Arformoterol—Gastrointestinal pain—Capecitabine—stomach cancer	0.000102	0.00071	CcSEcCtD
Arformoterol—Mediastinal disorder—Doxorubicin—stomach cancer	0.000102	0.00071	CcSEcCtD
Arformoterol—Body temperature increased—Docetaxel—stomach cancer	0.000101	0.000709	CcSEcCtD
Arformoterol—Abdominal pain—Docetaxel—stomach cancer	0.000101	0.000709	CcSEcCtD
Arformoterol—Arrhythmia—Doxorubicin—stomach cancer	0.000101	0.000704	CcSEcCtD
Arformoterol—Cough—Methotrexate—stomach cancer	9.89e-05	0.000691	CcSEcCtD
Arformoterol—Mental disorder—Doxorubicin—stomach cancer	9.88e-05	0.00069	CcSEcCtD
Arformoterol—Urticaria—Capecitabine—stomach cancer	9.87e-05	0.00069	CcSEcCtD
Arformoterol—Ill-defined disorder—Epirubicin—stomach cancer	9.84e-05	0.000688	CcSEcCtD
Arformoterol—Abdominal pain—Capecitabine—stomach cancer	9.83e-05	0.000686	CcSEcCtD
Arformoterol—Body temperature increased—Capecitabine—stomach cancer	9.83e-05	0.000686	CcSEcCtD
Arformoterol—Malnutrition—Doxorubicin—stomach cancer	9.82e-05	0.000686	CcSEcCtD
Arformoterol—Agitation—Epirubicin—stomach cancer	9.75e-05	0.000681	CcSEcCtD
Arformoterol—Chest pain—Methotrexate—stomach cancer	9.65e-05	0.000674	CcSEcCtD
Arformoterol—Arthralgia—Methotrexate—stomach cancer	9.65e-05	0.000674	CcSEcCtD
Arformoterol—Myalgia—Methotrexate—stomach cancer	9.65e-05	0.000674	CcSEcCtD
Arformoterol—Tension—Doxorubicin—stomach cancer	9.63e-05	0.000673	CcSEcCtD
Arformoterol—Dysgeusia—Doxorubicin—stomach cancer	9.61e-05	0.000672	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	9.59e-05	0.00067	CcSEcCtD
Arformoterol—Malaise—Epirubicin—stomach cancer	9.57e-05	0.000668	CcSEcCtD
Arformoterol—Discomfort—Methotrexate—stomach cancer	9.54e-05	0.000666	CcSEcCtD
Arformoterol—Nervousness—Doxorubicin—stomach cancer	9.53e-05	0.000666	CcSEcCtD
Arformoterol—Back pain—Doxorubicin—stomach cancer	9.5e-05	0.000663	CcSEcCtD
Arformoterol—Hypersensitivity—Docetaxel—stomach cancer	9.46e-05	0.000661	CcSEcCtD
Arformoterol—Muscle spasms—Doxorubicin—stomach cancer	9.44e-05	0.000659	CcSEcCtD
Arformoterol—Palpitations—Epirubicin—stomach cancer	9.38e-05	0.000655	CcSEcCtD
Arformoterol—Cough—Epirubicin—stomach cancer	9.26e-05	0.000647	CcSEcCtD
Arformoterol—Anaphylactic shock—Methotrexate—stomach cancer	9.25e-05	0.000646	CcSEcCtD
Arformoterol—Asthenia—Docetaxel—stomach cancer	9.21e-05	0.000644	CcSEcCtD
Arformoterol—Infection—Methotrexate—stomach cancer	9.19e-05	0.000642	CcSEcCtD
Arformoterol—Hypertension—Epirubicin—stomach cancer	9.16e-05	0.00064	CcSEcCtD
Arformoterol—Hypersensitivity—Capecitabine—stomach cancer	9.16e-05	0.00064	CcSEcCtD
Arformoterol—Ill-defined disorder—Doxorubicin—stomach cancer	9.11e-05	0.000636	CcSEcCtD
Arformoterol—Pruritus—Docetaxel—stomach cancer	9.08e-05	0.000635	CcSEcCtD
Arformoterol—Nervous system disorder—Methotrexate—stomach cancer	9.07e-05	0.000634	CcSEcCtD
Arformoterol—Arthralgia—Epirubicin—stomach cancer	9.03e-05	0.000631	CcSEcCtD
Arformoterol—Chest pain—Epirubicin—stomach cancer	9.03e-05	0.000631	CcSEcCtD
Arformoterol—Myalgia—Epirubicin—stomach cancer	9.03e-05	0.000631	CcSEcCtD
Arformoterol—Agitation—Doxorubicin—stomach cancer	9.02e-05	0.00063	CcSEcCtD
Arformoterol—Anxiety—Epirubicin—stomach cancer	9e-05	0.000629	CcSEcCtD
Arformoterol—Skin disorder—Methotrexate—stomach cancer	8.99e-05	0.000628	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	8.97e-05	0.000627	CcSEcCtD
Arformoterol—Discomfort—Epirubicin—stomach cancer	8.92e-05	0.000624	CcSEcCtD
Arformoterol—Asthenia—Capecitabine—stomach cancer	8.92e-05	0.000623	CcSEcCtD
Arformoterol—Malaise—Doxorubicin—stomach cancer	8.85e-05	0.000619	CcSEcCtD
Arformoterol—Dry mouth—Epirubicin—stomach cancer	8.83e-05	0.000617	CcSEcCtD
Arformoterol—Pruritus—Capecitabine—stomach cancer	8.79e-05	0.000614	CcSEcCtD
Arformoterol—Diarrhoea—Docetaxel—stomach cancer	8.78e-05	0.000614	CcSEcCtD
Arformoterol—Palpitations—Doxorubicin—stomach cancer	8.68e-05	0.000606	CcSEcCtD
Arformoterol—Oedema—Epirubicin—stomach cancer	8.66e-05	0.000605	CcSEcCtD
Arformoterol—Anaphylactic shock—Epirubicin—stomach cancer	8.66e-05	0.000605	CcSEcCtD
Arformoterol—Hypotension—Methotrexate—stomach cancer	8.65e-05	0.000604	CcSEcCtD
Arformoterol—Infection—Epirubicin—stomach cancer	8.6e-05	0.000601	CcSEcCtD
Arformoterol—Cough—Doxorubicin—stomach cancer	8.57e-05	0.000599	CcSEcCtD
Arformoterol—Diarrhoea—Capecitabine—stomach cancer	8.5e-05	0.000594	CcSEcCtD
Arformoterol—Nervous system disorder—Epirubicin—stomach cancer	8.49e-05	0.000593	CcSEcCtD
Arformoterol—Dizziness—Docetaxel—stomach cancer	8.49e-05	0.000593	CcSEcCtD
Arformoterol—Hypertension—Doxorubicin—stomach cancer	8.48e-05	0.000592	CcSEcCtD
Arformoterol—Tachycardia—Epirubicin—stomach cancer	8.45e-05	0.00059	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Methotrexate—stomach cancer	8.43e-05	0.000589	CcSEcCtD
Arformoterol—Skin disorder—Epirubicin—stomach cancer	8.41e-05	0.000588	CcSEcCtD
Arformoterol—Insomnia—Methotrexate—stomach cancer	8.37e-05	0.000585	CcSEcCtD
Arformoterol—Chest pain—Doxorubicin—stomach cancer	8.36e-05	0.000584	CcSEcCtD
Arformoterol—Arthralgia—Doxorubicin—stomach cancer	8.36e-05	0.000584	CcSEcCtD
Arformoterol—Myalgia—Doxorubicin—stomach cancer	8.36e-05	0.000584	CcSEcCtD
Arformoterol—Anxiety—Doxorubicin—stomach cancer	8.33e-05	0.000582	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	8.3e-05	0.00058	CcSEcCtD
Arformoterol—Discomfort—Doxorubicin—stomach cancer	8.26e-05	0.000577	CcSEcCtD
Arformoterol—Dyspnoea—Methotrexate—stomach cancer	8.25e-05	0.000576	CcSEcCtD
Arformoterol—Somnolence—Methotrexate—stomach cancer	8.23e-05	0.000575	CcSEcCtD
Arformoterol—Dizziness—Capecitabine—stomach cancer	8.22e-05	0.000574	CcSEcCtD
Arformoterol—Dry mouth—Doxorubicin—stomach cancer	8.17e-05	0.000571	CcSEcCtD
Arformoterol—Vomiting—Docetaxel—stomach cancer	8.16e-05	0.00057	CcSEcCtD
Arformoterol—Dyspepsia—Methotrexate—stomach cancer	8.14e-05	0.000569	CcSEcCtD
Arformoterol—Rash—Docetaxel—stomach cancer	8.09e-05	0.000566	CcSEcCtD
Arformoterol—Hypotension—Epirubicin—stomach cancer	8.09e-05	0.000565	CcSEcCtD
Arformoterol—Dermatitis—Docetaxel—stomach cancer	8.09e-05	0.000565	CcSEcCtD
Arformoterol—Headache—Docetaxel—stomach cancer	8.04e-05	0.000562	CcSEcCtD
Arformoterol—Oedema—Doxorubicin—stomach cancer	8.01e-05	0.00056	CcSEcCtD
Arformoterol—Anaphylactic shock—Doxorubicin—stomach cancer	8.01e-05	0.00056	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Methotrexate—stomach cancer	7.99e-05	0.000558	CcSEcCtD
Arformoterol—Fatigue—Methotrexate—stomach cancer	7.98e-05	0.000557	CcSEcCtD
Arformoterol—Infection—Doxorubicin—stomach cancer	7.96e-05	0.000556	CcSEcCtD
Arformoterol—Pain—Methotrexate—stomach cancer	7.91e-05	0.000553	CcSEcCtD
Arformoterol—Vomiting—Capecitabine—stomach cancer	7.9e-05	0.000552	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Epirubicin—stomach cancer	7.89e-05	0.000551	CcSEcCtD
Arformoterol—Nervous system disorder—Doxorubicin—stomach cancer	7.86e-05	0.000549	CcSEcCtD
Arformoterol—Rash—Capecitabine—stomach cancer	7.84e-05	0.000548	CcSEcCtD
Arformoterol—Insomnia—Epirubicin—stomach cancer	7.83e-05	0.000547	CcSEcCtD
Arformoterol—Dermatitis—Capecitabine—stomach cancer	7.83e-05	0.000547	CcSEcCtD
Arformoterol—Tachycardia—Doxorubicin—stomach cancer	7.82e-05	0.000546	CcSEcCtD
Arformoterol—Headache—Capecitabine—stomach cancer	7.79e-05	0.000544	CcSEcCtD
Arformoterol—Skin disorder—Doxorubicin—stomach cancer	7.78e-05	0.000544	CcSEcCtD
Arformoterol—Dyspnoea—Epirubicin—stomach cancer	7.72e-05	0.000539	CcSEcCtD
Arformoterol—Somnolence—Epirubicin—stomach cancer	7.7e-05	0.000538	CcSEcCtD
Arformoterol—Nausea—Docetaxel—stomach cancer	7.63e-05	0.000533	CcSEcCtD
Arformoterol—Feeling abnormal—Methotrexate—stomach cancer	7.62e-05	0.000533	CcSEcCtD
Arformoterol—Dyspepsia—Epirubicin—stomach cancer	7.62e-05	0.000533	CcSEcCtD
Arformoterol—Gastrointestinal pain—Methotrexate—stomach cancer	7.57e-05	0.000529	CcSEcCtD
Arformoterol—Hypotension—Doxorubicin—stomach cancer	7.49e-05	0.000523	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Epirubicin—stomach cancer	7.48e-05	0.000522	CcSEcCtD
Arformoterol—Fatigue—Epirubicin—stomach cancer	7.47e-05	0.000522	CcSEcCtD
Arformoterol—Constipation—Epirubicin—stomach cancer	7.4e-05	0.000517	CcSEcCtD
Arformoterol—Pain—Epirubicin—stomach cancer	7.4e-05	0.000517	CcSEcCtD
Arformoterol—Nausea—Capecitabine—stomach cancer	7.38e-05	0.000516	CcSEcCtD
Arformoterol—Urticaria—Methotrexate—stomach cancer	7.35e-05	0.000514	CcSEcCtD
Arformoterol—Abdominal pain—Methotrexate—stomach cancer	7.31e-05	0.000511	CcSEcCtD
Arformoterol—Body temperature increased—Methotrexate—stomach cancer	7.31e-05	0.000511	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Doxorubicin—stomach cancer	7.3e-05	0.00051	CcSEcCtD
Arformoterol—Insomnia—Doxorubicin—stomach cancer	7.25e-05	0.000506	CcSEcCtD
Arformoterol—Dyspnoea—Doxorubicin—stomach cancer	7.14e-05	0.000499	CcSEcCtD
Arformoterol—Feeling abnormal—Epirubicin—stomach cancer	7.14e-05	0.000499	CcSEcCtD
Arformoterol—Somnolence—Doxorubicin—stomach cancer	7.12e-05	0.000498	CcSEcCtD
Arformoterol—Gastrointestinal pain—Epirubicin—stomach cancer	7.08e-05	0.000495	CcSEcCtD
Arformoterol—Dyspepsia—Doxorubicin—stomach cancer	7.05e-05	0.000493	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Doxorubicin—stomach cancer	6.92e-05	0.000483	CcSEcCtD
Arformoterol—Fatigue—Doxorubicin—stomach cancer	6.91e-05	0.000483	CcSEcCtD
Arformoterol—Urticaria—Epirubicin—stomach cancer	6.88e-05	0.000481	CcSEcCtD
Arformoterol—Pain—Doxorubicin—stomach cancer	6.85e-05	0.000479	CcSEcCtD
Arformoterol—Constipation—Doxorubicin—stomach cancer	6.85e-05	0.000479	CcSEcCtD
Arformoterol—Abdominal pain—Epirubicin—stomach cancer	6.85e-05	0.000478	CcSEcCtD
Arformoterol—Body temperature increased—Epirubicin—stomach cancer	6.85e-05	0.000478	CcSEcCtD
Arformoterol—Hypersensitivity—Methotrexate—stomach cancer	6.82e-05	0.000476	CcSEcCtD
Arformoterol—Asthenia—Methotrexate—stomach cancer	6.64e-05	0.000464	CcSEcCtD
Arformoterol—Feeling abnormal—Doxorubicin—stomach cancer	6.6e-05	0.000461	CcSEcCtD
Arformoterol—Gastrointestinal pain—Doxorubicin—stomach cancer	6.55e-05	0.000458	CcSEcCtD
Arformoterol—Pruritus—Methotrexate—stomach cancer	6.55e-05	0.000457	CcSEcCtD
Arformoterol—Hypersensitivity—Epirubicin—stomach cancer	6.38e-05	0.000446	CcSEcCtD
Arformoterol—Urticaria—Doxorubicin—stomach cancer	6.36e-05	0.000445	CcSEcCtD
Arformoterol—Abdominal pain—Doxorubicin—stomach cancer	6.33e-05	0.000442	CcSEcCtD
Arformoterol—Body temperature increased—Doxorubicin—stomach cancer	6.33e-05	0.000442	CcSEcCtD
Arformoterol—Diarrhoea—Methotrexate—stomach cancer	6.33e-05	0.000442	CcSEcCtD
Arformoterol—Asthenia—Epirubicin—stomach cancer	6.21e-05	0.000434	CcSEcCtD
Arformoterol—Pruritus—Epirubicin—stomach cancer	6.13e-05	0.000428	CcSEcCtD
Arformoterol—Dizziness—Methotrexate—stomach cancer	6.12e-05	0.000427	CcSEcCtD
Arformoterol—Diarrhoea—Epirubicin—stomach cancer	5.92e-05	0.000414	CcSEcCtD
Arformoterol—Hypersensitivity—Doxorubicin—stomach cancer	5.9e-05	0.000412	CcSEcCtD
Arformoterol—Vomiting—Methotrexate—stomach cancer	5.88e-05	0.000411	CcSEcCtD
Arformoterol—Rash—Methotrexate—stomach cancer	5.83e-05	0.000408	CcSEcCtD
Arformoterol—Dermatitis—Methotrexate—stomach cancer	5.83e-05	0.000407	CcSEcCtD
Arformoterol—Headache—Methotrexate—stomach cancer	5.8e-05	0.000405	CcSEcCtD
Arformoterol—Asthenia—Doxorubicin—stomach cancer	5.75e-05	0.000402	CcSEcCtD
Arformoterol—Dizziness—Epirubicin—stomach cancer	5.73e-05	0.0004	CcSEcCtD
Arformoterol—Pruritus—Doxorubicin—stomach cancer	5.67e-05	0.000396	CcSEcCtD
Arformoterol—Vomiting—Epirubicin—stomach cancer	5.51e-05	0.000385	CcSEcCtD
Arformoterol—Nausea—Methotrexate—stomach cancer	5.5e-05	0.000384	CcSEcCtD
Arformoterol—Diarrhoea—Doxorubicin—stomach cancer	5.48e-05	0.000383	CcSEcCtD
Arformoterol—Rash—Epirubicin—stomach cancer	5.46e-05	0.000381	CcSEcCtD
Arformoterol—Dermatitis—Epirubicin—stomach cancer	5.45e-05	0.000381	CcSEcCtD
Arformoterol—Headache—Epirubicin—stomach cancer	5.42e-05	0.000379	CcSEcCtD
Arformoterol—Dizziness—Doxorubicin—stomach cancer	5.3e-05	0.00037	CcSEcCtD
Arformoterol—Nausea—Epirubicin—stomach cancer	5.14e-05	0.000359	CcSEcCtD
Arformoterol—Vomiting—Doxorubicin—stomach cancer	5.09e-05	0.000356	CcSEcCtD
Arformoterol—Rash—Doxorubicin—stomach cancer	5.05e-05	0.000353	CcSEcCtD
Arformoterol—Dermatitis—Doxorubicin—stomach cancer	5.05e-05	0.000353	CcSEcCtD
Arformoterol—Headache—Doxorubicin—stomach cancer	5.02e-05	0.000351	CcSEcCtD
Arformoterol—Nausea—Doxorubicin—stomach cancer	4.76e-05	0.000332	CcSEcCtD
Arformoterol—ADRB2—GPCR ligand binding—CXCL8—stomach cancer	1.08e-05	0.00054	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PLIN2—stomach cancer	1.06e-05	0.00053	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PLIN2—stomach cancer	1.05e-05	0.000525	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PLCE1—stomach cancer	1.04e-05	0.000521	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—ALDH7A1—stomach cancer	1.04e-05	0.000521	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—CA2—stomach cancer	1.03e-05	0.000515	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—CA2—stomach cancer	1.02e-05	0.000511	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—NT5E—stomach cancer	1e-05	0.000502	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PGAM1—stomach cancer	1e-05	0.000502	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—GSTT1—stomach cancer	1e-05	0.000502	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—UMPS—stomach cancer	9.98e-06	0.000499	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—NT5E—stomach cancer	9.95e-06	0.000498	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PGAM1—stomach cancer	9.95e-06	0.000498	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—AKR1C3—stomach cancer	9.65e-06	0.000483	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PLCE1—stomach cancer	9.57e-06	0.000479	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—ALDH7A1—stomach cancer	9.57e-06	0.000479	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—HSPB1—stomach cancer	9.49e-06	0.000475	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—AGTR2—stomach cancer	9.49e-06	0.000475	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PLCE1—stomach cancer	9.49e-06	0.000475	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—ALDH7A1—stomach cancer	9.49e-06	0.000475	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—ENO1—stomach cancer	9.4e-06	0.000471	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—F2R—stomach cancer	9.39e-06	0.00047	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—BMP2—stomach cancer	9.39e-06	0.00047	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—AGTR2—stomach cancer	9.29e-06	0.000465	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—HSPB1—stomach cancer	9.29e-06	0.000465	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—ECHS1—stomach cancer	9.28e-06	0.000464	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PDHA1—stomach cancer	9.28e-06	0.000464	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—AKR1C3—stomach cancer	9.23e-06	0.000462	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—F2R—stomach cancer	9.18e-06	0.00046	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—BMP2—stomach cancer	9.18e-06	0.00046	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—UMPS—stomach cancer	9.18e-06	0.000459	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—HTR1A—stomach cancer	9.14e-06	0.000457	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—UMPS—stomach cancer	9.1e-06	0.000455	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—AKR1C3—stomach cancer	9.03e-06	0.000452	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—HTR1A—stomach cancer	8.94e-06	0.000447	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—PRKCB—stomach cancer	8.85e-06	0.000443	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—ANXA1—stomach cancer	8.82e-06	0.000442	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—TYMP—stomach cancer	8.72e-06	0.000437	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—FADS1—stomach cancer	8.72e-06	0.000437	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—PRKCB—stomach cancer	8.65e-06	0.000433	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—ANXA1—stomach cancer	8.63e-06	0.000432	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PDHA1—stomach cancer	8.53e-06	0.000427	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—ECHS1—stomach cancer	8.53e-06	0.000427	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PDHA1—stomach cancer	8.46e-06	0.000423	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—ECHS1—stomach cancer	8.46e-06	0.000423	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—ADRB1—stomach cancer	8.36e-06	0.000418	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—CD44—stomach cancer	8.34e-06	0.000417	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—SREBF2—stomach cancer	8.17e-06	0.000409	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—RPS6—stomach cancer	8.17e-06	0.000409	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—RORA—stomach cancer	8.07e-06	0.000404	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—PRKCB—stomach cancer	8.03e-06	0.000402	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—TYMP—stomach cancer	8.02e-06	0.000402	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—FADS1—stomach cancer	8.02e-06	0.000402	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—IL6ST—stomach cancer	8e-06	0.0004	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—RPS6—stomach cancer	7.99e-06	0.0004	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—FADS1—stomach cancer	7.95e-06	0.000398	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—TYMP—stomach cancer	7.95e-06	0.000398	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—PRKCB—stomach cancer	7.86e-06	0.000393	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—IL6ST—stomach cancer	7.83e-06	0.000392	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—ALDOB—stomach cancer	7.56e-06	0.000379	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—SREBF2—stomach cancer	7.51e-06	0.000376	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—HBEGF—stomach cancer	7.5e-06	0.000376	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—SREBF2—stomach cancer	7.45e-06	0.000373	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—RORA—stomach cancer	7.42e-06	0.000372	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—RORA—stomach cancer	7.36e-06	0.000368	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—HBEGF—stomach cancer	7.34e-06	0.000367	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—IL6R—stomach cancer	7.14e-06	0.000357	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	7.13e-06	0.000357	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	7.12e-06	0.000356	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—RHOA—stomach cancer	7.1e-06	0.000355	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PPP2R1A—stomach cancer	7.09e-06	0.000355	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—ALOX5—stomach cancer	7.03e-06	0.000352	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—IL6R—stomach cancer	6.98e-06	0.00035	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—ALDOB—stomach cancer	6.96e-06	0.000348	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—GSTP1—stomach cancer	6.95e-06	0.000348	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—RHOA—stomach cancer	6.95e-06	0.000348	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—ADRB2—stomach cancer	6.92e-06	0.000347	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—DPYD—stomach cancer	6.92e-06	0.000346	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—ALDOB—stomach cancer	6.9e-06	0.000345	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—HMOX1—stomach cancer	6.86e-06	0.000343	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PPP2R1A—stomach cancer	6.79e-06	0.00034	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PPP2R1A—stomach cancer	6.64e-06	0.000332	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	6.5e-06	0.000325	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	6.49e-06	0.000325	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—ALOX5—stomach cancer	6.47e-06	0.000324	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—TYMS—stomach cancer	6.46e-06	0.000324	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—RHOA—stomach cancer	6.45e-06	0.000323	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—ALOX5—stomach cancer	6.41e-06	0.000321	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—GSTM1—stomach cancer	6.39e-06	0.00032	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—DPYD—stomach cancer	6.36e-06	0.000318	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—RHOA—stomach cancer	6.31e-06	0.000316	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—DPYD—stomach cancer	6.31e-06	0.000316	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—SMAD4—stomach cancer	6.3e-06	0.000315	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	6.27e-06	0.000314	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—CXCL8—stomach cancer	6.23e-06	0.000312	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—SMAD4—stomach cancer	6.16e-06	0.000308	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—GSTT1—stomach cancer	6.12e-06	0.000306	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—CXCL8—stomach cancer	6.1e-06	0.000305	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—CYP2A6—stomach cancer	6.05e-06	0.000303	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—ERCC2—stomach cancer	6.01e-06	0.000301	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—FYN—stomach cancer	5.98e-06	0.000299	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—AKR1C3—stomach cancer	5.88e-06	0.000294	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—FYN—stomach cancer	5.85e-06	0.000293	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—ENO1—stomach cancer	5.73e-06	0.000287	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	5.72e-06	0.000286	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—CXCL8—stomach cancer	5.66e-06	0.000283	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—MTHFR—stomach cancer	5.65e-06	0.000283	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—stomach cancer	5.64e-06	0.000282	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—GSTT1—stomach cancer	5.63e-06	0.000282	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—FGFR2—stomach cancer	5.62e-06	0.000281	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—GSTT1—stomach cancer	5.58e-06	0.000279	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—CYP2A6—stomach cancer	5.56e-06	0.000278	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—CXCL8—stomach cancer	5.54e-06	0.000277	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—CYP2A6—stomach cancer	5.51e-06	0.000276	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—FGFR2—stomach cancer	5.49e-06	0.000275	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—AKR1C3—stomach cancer	5.41e-06	0.000271	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—AKR1C3—stomach cancer	5.36e-06	0.000268	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—ENO1—stomach cancer	5.27e-06	0.000264	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—ENO1—stomach cancer	5.23e-06	0.000262	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—CAV1—stomach cancer	5.21e-06	0.000261	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—APOA1—stomach cancer	5.2e-06	0.00026	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—IRS2—stomach cancer	5.14e-06	0.000257	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	5.14e-06	0.000257	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—CD44—stomach cancer	5.08e-06	0.000254	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—IRS2—stomach cancer	5.03e-06	0.000252	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CAV1—stomach cancer	4.99e-06	0.00025	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—APOA1—stomach cancer	4.97e-06	0.000249	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	4.93e-06	0.000247	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CAV1—stomach cancer	4.88e-06	0.000244	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—APOA1—stomach cancer	4.87e-06	0.000244	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PRKCB—stomach cancer	4.75e-06	0.000238	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—IL6ST—stomach cancer	4.73e-06	0.000237	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—CD44—stomach cancer	4.68e-06	0.000234	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PRKCB—stomach cancer	4.64e-06	0.000232	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—CD44—stomach cancer	4.64e-06	0.000232	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—IL6ST—stomach cancer	4.62e-06	0.000231	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PPARG—stomach cancer	4.58e-06	0.000229	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—APC—stomach cancer	4.54e-06	0.000227	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	4.5e-06	0.000225	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—APC—stomach cancer	4.44e-06	0.000222	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—MAPK3—stomach cancer	4.35e-06	0.000218	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PPP2R1A—stomach cancer	4.32e-06	0.000216	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—MAPK3—stomach cancer	4.26e-06	0.000213	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—GSTP1—stomach cancer	4.24e-06	0.000212	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—IL6R—stomach cancer	4.22e-06	0.000211	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—HMOX1—stomach cancer	4.18e-06	0.000209	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—MAPK1—stomach cancer	4.14e-06	0.000207	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—EGFR—stomach cancer	4.14e-06	0.000207	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—IL6R—stomach cancer	4.13e-06	0.000206	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—ALB—stomach cancer	4.12e-06	0.000206	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—MAPK1—stomach cancer	4.05e-06	0.000203	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—EGFR—stomach cancer	4.05e-06	0.000203	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PPP2R1A—stomach cancer	3.98e-06	0.000199	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—PIK3CA—stomach cancer	3.95e-06	0.000198	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—SERPINE1—stomach cancer	3.95e-06	0.000198	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—TYMS—stomach cancer	3.94e-06	0.000197	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PPP2R1A—stomach cancer	3.94e-06	0.000197	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—NOS3—stomach cancer	3.94e-06	0.000197	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—KRAS—stomach cancer	3.91e-06	0.000196	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—GSTP1—stomach cancer	3.9e-06	0.000195	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—GSTM1—stomach cancer	3.9e-06	0.000195	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—PIK3CA—stomach cancer	3.87e-06	0.000194	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—GSTP1—stomach cancer	3.87e-06	0.000193	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—SERPINE1—stomach cancer	3.86e-06	0.000193	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—HMOX1—stomach cancer	3.85e-06	0.000192	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—KRAS—stomach cancer	3.82e-06	0.000191	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—HMOX1—stomach cancer	3.81e-06	0.000191	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—RHOA—stomach cancer	3.81e-06	0.000191	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—NOS3—stomach cancer	3.77e-06	0.000189	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—RHOA—stomach cancer	3.73e-06	0.000187	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—NOS3—stomach cancer	3.69e-06	0.000185	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—ERCC2—stomach cancer	3.66e-06	0.000183	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—TYMS—stomach cancer	3.63e-06	0.000181	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PTGS2—stomach cancer	3.6e-06	0.00018	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—TYMS—stomach cancer	3.59e-06	0.00018	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—PIK3CA—stomach cancer	3.59e-06	0.00018	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—GSTM1—stomach cancer	3.58e-06	0.000179	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—GSTM1—stomach cancer	3.55e-06	0.000178	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—ERBB2—stomach cancer	3.53e-06	0.000177	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—PIK3CA—stomach cancer	3.51e-06	0.000176	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—ERBB2—stomach cancer	3.45e-06	0.000173	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—MTHFR—stomach cancer	3.44e-06	0.000172	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—ERCC2—stomach cancer	3.37e-06	0.000169	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CXCL8—stomach cancer	3.34e-06	0.000167	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—ERCC2—stomach cancer	3.34e-06	0.000167	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—HRAS—stomach cancer	3.32e-06	0.000166	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CXCL8—stomach cancer	3.27e-06	0.000164	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CDKN1B—stomach cancer	3.27e-06	0.000163	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—HRAS—stomach cancer	3.25e-06	0.000163	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CDKN1B—stomach cancer	3.19e-06	0.00016	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—IL6—stomach cancer	3.18e-06	0.000159	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—CAV1—stomach cancer	3.18e-06	0.000159	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—APOA1—stomach cancer	3.17e-06	0.000159	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—MTHFR—stomach cancer	3.17e-06	0.000159	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—MTHFR—stomach cancer	3.14e-06	0.000157	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CCND1—stomach cancer	3.12e-06	0.000156	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—IL6—stomach cancer	3.11e-06	0.000156	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—JUN—stomach cancer	3.11e-06	0.000156	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CCND1—stomach cancer	3.05e-06	0.000153	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—JUN—stomach cancer	3.04e-06	0.000152	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.03e-06	0.000152	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—MMP9—stomach cancer	3.02e-06	0.000151	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CDKN1A—stomach cancer	3.01e-06	0.000151	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—MMP9—stomach cancer	2.96e-06	0.000148	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CDKN1A—stomach cancer	2.95e-06	0.000148	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—MAPK8—stomach cancer	2.94e-06	0.000147	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—CAV1—stomach cancer	2.92e-06	0.000146	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—APOA1—stomach cancer	2.91e-06	0.000146	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—CAV1—stomach cancer	2.9e-06	0.000145	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—APOA1—stomach cancer	2.89e-06	0.000145	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—MAPK8—stomach cancer	2.88e-06	0.000144	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PPARG—stomach cancer	2.79e-06	0.00014	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.77e-06	0.000138	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—VEGFA—stomach cancer	2.72e-06	0.000136	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—STAT3—stomach cancer	2.69e-06	0.000135	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—VEGFA—stomach cancer	2.66e-06	0.000133	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—STAT3—stomach cancer	2.63e-06	0.000132	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—MAPK3—stomach cancer	2.57e-06	0.000129	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PPARG—stomach cancer	2.57e-06	0.000129	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PPARG—stomach cancer	2.55e-06	0.000127	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—MAPK3—stomach cancer	2.51e-06	0.000126	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—ALB—stomach cancer	2.51e-06	0.000126	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—MYC—stomach cancer	2.5e-06	0.000125	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—MAPK1—stomach cancer	2.44e-06	0.000122	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—MYC—stomach cancer	2.44e-06	0.000122	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—EGFR—stomach cancer	2.44e-06	0.000122	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—NOS3—stomach cancer	2.4e-06	0.00012	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—MAPK1—stomach cancer	2.39e-06	0.00012	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—EGFR—stomach cancer	2.39e-06	0.00012	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—KRAS—stomach cancer	2.31e-06	0.000116	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—ALB—stomach cancer	2.31e-06	0.000116	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—ALB—stomach cancer	2.29e-06	0.000115	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—KRAS—stomach cancer	2.26e-06	0.000113	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PIK3CA—stomach cancer	2.22e-06	0.000111	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—NOS3—stomach cancer	2.21e-06	0.000111	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PTGS2—stomach cancer	2.2e-06	0.00011	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—NOS3—stomach cancer	2.19e-06	0.00011	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PIK3CA—stomach cancer	2.12e-06	0.000106	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PIK3CA—stomach cancer	2.08e-06	0.000104	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—TP53—stomach cancer	2.05e-06	0.000103	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PTGS2—stomach cancer	2.02e-06	0.000101	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—TP53—stomach cancer	2.01e-06	0.0001	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PTGS2—stomach cancer	2e-06	0.0001	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—HRAS—stomach cancer	1.96e-06	9.82e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—HRAS—stomach cancer	1.92e-06	9.61e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—IL6—stomach cancer	1.88e-06	9.4e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—IL6—stomach cancer	1.84e-06	9.2e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PIK3CA—stomach cancer	1.35e-06	6.76e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PIK3CA—stomach cancer	1.24e-06	6.22e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PIK3CA—stomach cancer	1.23e-06	6.17e-05	CbGpPWpGaD
